Nexus Laboratory,
run on receipts.

Nexus Laboratory mission

Nexus Laboratory exists to supply research peptides and small- molecule research compounds whose analytical chemistry is transparent. Finalized batches publish public certificate records containing only the analytical fields supported for the represented lot; lots awaiting final documentation are labeled certificate pending instead of showing assay values. The company ships within the United States via USPS. The catalog currently spans 95 compounds across 14 research areas, with the certificate state visible on each product record.

Verification philosophy

Nexus reads each finalized lot on its own published evidence. Reverse-phase HPLC can report area-percent purity, mass spectrometry can support molecular identity, and additional screens such as endotoxin are shown only where they are actually present. Testing is performed by external laboratories — not by Nexus. Independence matters because in-house verification carries a structural conflict of interest: the same entity that benefits from a high-purity claim is reporting the data behind it.

Nexus keeps the public boundary explicit. Product pages link to the published certificate state, finalized records expose the reported fields held for the represented lot, and pending records do not leak unfinished values. Where originating reports, raw traces, laboratory identity, or accreditation scope are not public, the record says so instead of inferring them. Read the methodology in full on the Lab Verified page.

Compound categories we supply

The 95-compound catalog is organized into 14 research areas: GLP-1 and metabolic peptides (semaglutide, tirzepatide, retatrutide, cagrilintide and blends); growth hormone secretagogues (GHRH analogs, GHRPs, IGF-family); healing and tissue-repair compounds (BPC-157, TB-500, KPV, LL-37, thymosin alpha-1); cosmetic peptides (GHK-Cu, AHK-Cu, matrixyl); Russian Khavinson bioregulators (15 short tetrapeptide bioregulators); cognitive and nootropic peptides (selank, semax, cerebrolysin, DSIP, P21); longevity and cellular-health peptides (epithalon, FOXO4-DRI, MOTS-c, humanin, SS-31, NAD+); melanocortin peptides, sexual-health research peptides, sleep peptides, mitochondrial-energy compounds, specialty research compounds, oral-format research compounds, and reconstitution solvents. Compound reference data — including CAS, molecular weight, sequence, and classification where available — lives in the peptide research database.

Compliance and research-use commitment

All Nexus Laboratory products are sold strictly for in-vitro research and analytical use. They are not pharmaceuticals, are not intended for human consumption or veterinary use, and Nexus does not provide therapeutic, dosing, or medical guidance under any circumstances. Customers are responsible for ensuring their research complies with applicable institutional, local, state, and federal regulations. The full compliance framing is documented in the regulatory disclaimer.